| NCT ID | NCT05997810 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Parathyroid Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 839 participants |
| Start Date | 2023-07-28 |
| Primary Completion | 2031-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 839 participants in total. It began in 2023-07-28 with a primary completion date of 2031-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).
Eligibility Criteria
Inclusion Criteria: * 1\. Diagnosed with hyperparathyroidism (primary, secondary, or tertiary), biochemically confirmed (e.g., serum calcium and/or intact PTH consistent with the underlying etiology), and undergoing clinically indicated management * Female and male patients * Age ≥ 18 years * Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable). Exclusion Criteria: * Patients with a history of cervicofacial irradiation. * Patients currently taking lithium or with a history of lithium use. * Pregnant patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05997810 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Parathyroid Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05997810 currently recruiting?
Yes, NCT05997810 is actively recruiting participants. Contact the research team at jaolsol@wustl.edu for enrollment information.
Where is the NCT05997810 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT05997810 clinical trial?
NCT05997810 is sponsored by Washington University School of Medicine. The trial plans to enroll 839 participants.